Although significant progress has been made in understanding the importance of Wnt signaling in the initiation of colorectal cancer, less is known about responses that accompany the reversal of oncogenic Wnt signaling. The aim of this study was to analyze in vivo and in vitro responses to an 'ideal' Wnt pathway inhibitor as a model for the therapeutic targeting of the pathway. A tetracycline-inducible transgenic mouse model expressing truncated b-catenin (DN89b-catenin) that exhibited a strong intestinal hyperplasia was analyzed during the removal of oncogenic b-catenin expression both in 3D 'crypt culture' and in vivo. Oncogenic Wnt signaling was rapidly and completely reversed. The strongest inhibition of Wnt target gene expression occurred within 24 h of doxycycline removal at which time the target genes Ascl2, Axin2 and C-myc were downregulated to levels below that in the control intestine. In vitro, the small molecule Wnt inhibitor CCT036477 induced a response within 4 h of treatment. By 7 days following doxycycline withdrawal, gene expression, cell proliferation and tissue morphology were undistinguishable from control animals.In conclusion, these results demonstrate that the reversal of Wnt signaling by inhibitors should ideally be studied within hours of treatment. The reversible system described, involving medium throughput in vitro approaches and rapid in vivo responses, should allow the rapid advance of early stage compounds into efficacy models that are more usually considered later in the drug discovery pipeline.
INTRODUCTION
The intestinal epithelium is organized into two functionally distinct compartments: the invaginating crypts of Lieberkuhn that contain stem cells and villus protrusions formed primarily from differentiated enterocytes.
The Wnt/b-catenin signaling pathway drives differentiation and proliferation within the crypt compartment. 1 In the absence of Wnt ligand, the cytoplasmic b-catenin protein is targeted for ubiquitin-mediated degradation by a multiprotein complex including the adenomatous polyposis coli (APC) tumor suppressor protein. 2 Wnt signaling inhibits b-catenin turnover, leading to its accumulation and translocation to the nucleus where it complexes with the T-cell factor/lymphoid enhancing factor transcription factors to induce transcription of genes including Ascl2, Axin2 and C-myc. 3 The importance of Wnt signaling for intestinal development has been demonstrated using both mouse models and organoid culture models. 4 --7 Inducible deletion of b-catenin led to a rapid and complete destruction of the crypt compartment that correlated with a reduction in cell proliferation and the terminal differentiation of stem cells. 4 The loss of intestinal crypts was similarly observed in transgenic mice lacking T-cell factor-4 and in animals overproducing the extracellular Wnt signaling inhibitor Dickkopf-1. 5, 6 In vitro, the Wnt pathway activator R-spondin1 was required for the survival and development of intestinal organoids in culture. 7 Mutations that constitutively activate canonical Wnt signaling constitute the most prevalent genetic abnormality in human colon cancer where 490% of tumors contain mutations that activate the pathway. 8 Mutations to b-catenin prevent the phosphorylation of N-terminal serine and threonine residues (S33, S37, T41 and S45) that are required for turnover leading to ligand-independent expression of the Wnt target genes. 9 Harada et al. 10 showed that Cre-loxP deletion of exon 3 of b-catenin (including S33, S37, T41 and S45 sequences) induced the formation of adenomatous intestinal polyps. Wong et al.
11
failed to identify tumor formation following expression of a b-catenin transgene lacking the 89 N-terminal amino acids (DN89b-catenin), but did observe increased crypt cell proliferation and apoptosis accompanied by a slowing of the cell migration within the crypt/villus axis. Romagnolo et al. 12 created a transgenic mouse model expressing a DN131 b-catenin protein and identified a similar increase in apoptosis along with multifocal dysplastic regions in the small intestine. Taken together, these results confirm the importance of the Wnt pathway and suggest that stabilization of b-catenin can be an initial step leading to colorectal cancer. Although the initiation of colorectal cancer following b-catenin mutation has been studied in detail, the more clinically important process of blocking oncogenic signaling has not been followed.
Here, we have characterized for the first time the regression of an intestinal hyperplasia using a doxycycline-dependent mouse model expressing mutant b-catenin. Time course analyses showed a surprisingly rapid restoration of the normal intestinal phenotype. In crypt organoids in vitro, mutant b-catenin was required for Wnt gene expression and cell survival. Transcriptional responses to the inhibition of Wnt signaling were extremely rapid. Loss of mutant b-catenin in vivo resulted in an active inhibition of target gene expression within 24 h whereas a small molecule inhibitor of Wnt signaling blocked targets within 4 h. The combined in vitro/in vivo models we describe should allow the early assessment of compound efficacy in drug discovery programs and emphasizes the importance of studying anti-Wnt signaling therapeutics at very early times after administration.
RESULTS
Expression of the tetracycline-inducible DN89b-catenin in vitro and in vivo A doxycycline-responsive promoter regulating expression of DN89-b-catenin was targeted downstream of the collagen 1a1 locus by FLP-FRT site-directed recombination. 13 The targeted embryonic stem cells already contained the doxycycline-regulated transactivator M2-rtTA gene under the control of the constitutively active ROSA26 promoter (Figure 1a) . 13 Three out of three analyzed clones were found to have integrated the transgene correctly and expression of the DN89b-catenin protein was dependent on doxycycline addition (Supplementary Figures 1A and B ). Mice were generated by diploid blastocyst injection. Following 10 days treatment with 2 mg/ml doxycycline in the drinking water, the expression of DN89b-catenin protein was noted in different tissues in mice, including the skin, liver, lung, stomach and intestine (Supplementary Figure 1C) . The global tissue transgene expression did not affect the animals over the timescale of the assays as the mice were viable after 15 days of treatment.
The intestinal expression of DN89b-catenin mRNA in Tet-ODN89b-catenin-rtTA mice was strongly induced (11 000-fold) 10 days after doxycycline treatment (P ¼ 0.03, Mann --Whitney, n ¼ 4; Figure 1b) . Mutant b-catenin mRNA was undetectable in the intestine samples from untreated mice (Supplementary Figure 2A) . Western blot analysis of intestinal tissues using the Myc epitope tag antibody showed the presence of DN89b-catenin protein in doxycycline-treated Tet-ODN89b-catenin-rtTA mice, but not in control or untreated mice (Figure 1c) . Immunolocalization showed cytoplasmic, but not nuclear, DN89b-catenin expression within both the crypt and villus compartments of doxycycline-treated Tet-ODN89b-catenin-rtTA mice (Figure 1d and Supplementary Figure 2B ). Nuclear accumulation of b-catenin was noted in the crypts of doxycycline-treated Tet-ODN89b-catenin-rtTA mice ( Figure 3c Figure 2C) . Taken together, these observations show low background levels and a strong induction of DN89b-catenin expression following doxycycline treatment.
Loss of DN89b-catenin expression after doxycycline removal The time course of responses to the removal of DN89b-catenin was determined by removing doxycycline from the water of TetODN89b-catenin mice that had been induced for 10 days. mRNA and protein expressions were assessed after 1, 2, 7 or 14 days of doxycycline removal. DN89b-catenin mRNA reverted to control levels within 1 day of doxycycline removal (P ¼ 0.11, Mann --Whitney, n ¼ 4; Figure 2a ). The rapid loss of DN89b-catenin mRNA expression was not unexpected as the half-life of doxycycline in mouse serum is estimated to be 3 h, suggesting that at least 99% of serum doxycycline would be excreted after 1 day.
14 Western blot analyses also showed a rapid loss of DN89b-catenin protein as protein was not detectable 1, 2, 7 or 14 days following doxycycline withdrawal (Figure 2b ). The rapid loss of DN89b-catenin, despite it being a stabilized form of b-catenin, was compatible with the previous work as the half-life of truncated b-catenin in melanoma cells has been estimated to be B4.5 h by comparison with 2 h for the wild-type protein. 15 The rapidity of the biological response is clear, but finer details of the dyamics are dependent on a complex interplay between the DN89b-catenin mRNA decay rate, intestinal doxycycline levels and the threshold for Tet-O-promoter activity in each intestinal cell type.
Upregulation of stabilized b-catenin strongly modifies the crypt compartment Histological analysis of the intestine samples from 10 day-induced DN89b-catenin mice revealed an enlarged crypt compartment (Figure 3ai ). The number of cells per half crypt was 29.0 ± 4.0 in induced versus 15.4 ± 0.4 in control animals (P ¼ 0.03, Mann --Whitney, n ¼ 4; Figure 3Ab ). The expansion of the crypt compartment was associated with increased cell proliferation. Crypts from induced Tet-ODN89b-catenin-rtTA mice showed raised levels of the S-phase marker Ki-67 and higher number of mitotic figures (5.84 ± 0.49% versus 2.83 ± 0.2% in control half crypts P ¼ 0.03, Mann --Whitney, n ¼ 4; Figure 3b and Supplementary Figure 3) . Apoptotic cell death as followed by active caspase-3 staining trended higher in doxycycline-treated crypts, but this was not statistically significant (38.8 ± 22.0 positive cells per 50 half crypts for Tet-ODN89b-catenin-rtTA mice and 5.6 ± 1.8 for control mice; P ¼ 0.19, Mann--Whitney, n ¼ 5; Figures 5a and b) . Active caspase-3 cells in mutant crypts were localized all along the enlarged crypt axis, in contrast with restricted apoptosis in the bottom of control crypts (Supplementary Figure 4) . Intestinal differentiation processes were partly altered following doxycycline treatment in TetODN89b-catenin-rtTA mice. Although the percentage of goblet and paneth cells per crypt was not changed (Supplementary Figure 5) , the cellular localization of paneth cells within the crypt compartment was strongly modified and was now distributed throughout the crypt-like area rather than being confined to their normal position at the crypt base (Supplementary Figure 6) .
After 10 days doxycycline treatment, the body weight of TetODN89b-catenin-rtTA mice was reduced by 13.8% compared with control mice (26.1 ± 0.6 g for control, 22.5 ± 0.8 g for mutant; Po0.01, Mann --Whitney, n ¼ 22 --25; Supplementary Figure 7) .
To confirm the involvement of the Wnt pathway in these profound changes, the accumulation of b-catenin in the nucleus of crypt cells was analyzed by immunohistochemistry using an antibody recognizing both endogenous and truncated b-catenin and the expression of known Wnt target genes was studied by quantitative reverse transcriptase (qRT) --PCR. As expected, after 10 days doxycycline treatment, a high number of cells in hyperproliferative crypts showed nuclear accumulation of b-catenin in Tet-ODN89b-catenin-rtTA mice ( Figure 3c ). In addition, the majority of the Wnt target genes (Ascl2, Axin2, C-myc and Ephb2, but not Lgr5 and Tiam1) were upregulated ( Figure 3d ). The level of endogenous b-catenin mRNA was not altered following 10-days doxycycline treatment in Tet-ODN89b-catenin-rtTA mice (data not shown).
In contrast to the phenotype seen in intestinal crypts, we did not observe any changes in the villus compartment 10-days after doxycycline treatment of Tet-ODN89b-catenin-rtTA mice even although DN89b-catenin protein was expressed in the villus (Figure 1d New approaches for anti-Wnt drug discovery T Jardé et al control (86.7 ± 4.3) and Tet-ODN89b-catenin-rtTA (98.7 ± 4.8) mice (P ¼ 0.09, Mann --Whitney, n ¼ 5; data not shown) and the villus cell marker alkaline phosphatase was expressed at similar levels in both groups of mice (data not shown). Lastly, no Ki-67 stained proliferating cells were detected in DN89b-catenin expressing or control villus tissues (Figure 3b ).
Reversal of the Wnt pathway induces rapid regression of the crypt compartment The effect of reversal of the Wnt pathway was rapid. After 1 day of doxycycline withdrawal, the crypt compartment of Tet-ODN89b-catenin-rtTA mice was reduced in size and by day 7, crypts from mutant mice were histologically indistinguishable from control crypts ( Figure 4a ). No statistically significant differences in cell numbers were noted between control and mutant mice after 1, 2, 7 or 14 days of doxycycline removal (Figure 4b ).
The rapid reduction in crypt cell number was associated with an equally rapid reduction in crypt cell proliferation. After 1 day without doxycycline, the Ki67-positive compartment in TetODN89b-catenin-rtTA mice was still enlarged by comparison with controls (Figure 4c ), but no significant difference were noted between the number of Ki67-positive cells and mitotic figures in crypts from control and Tet-ODN89b-catenin-rtTA mice (Figure 4d and Supplementary Figure 3) . After 2 days of doxycycline removal, no significant differences were observed between the number of Ki67-positive cells and mitotic figures in control and Tet-ODN89b-catenin-rtTA mice (Figures 4c and d and Supplementary Figure 3) . After 7 and 14 days without doxycycline, the number of Ki67-positive and mitotic cells in the intestine was similar between control and Tet-ODN89b-catenin-rtTA mice (Figures 4c and d and  Supplementary Figure 3) . The rapid decrease of cell number in the crypt compartment of Tet-ODN89b-catenin-rtTA mice following doxycycline removal was associated with raised levels of apoptosis (Figures 5a and b) . The number of caspase-3 positive cells in 50 half crypts, including data from both 1-day and 2-day doxycycline removal, was 14.6±3.1 for Tet-ODN89b-catenin-rtTA mice and 6.0 ± 1.1 for control mice (P ¼ 0.03, Mann --Whitney, n ¼ 10; New approaches for anti-Wnt drug discovery T Jardé et al
The removal of doxycycline was associated with profound alterations of gene expression in the intestine. qRT --PCR analysis showed that multiple Wnt target genes were actively downregulated 1 day after doxycycline removal in Tet-ODN89b-cateninrtTA by comparison with controls ( Figure 5c ). After 2 days, Axin2, C-myc, Ephb2 and Lgr5 were still significantly repressed whereas expression levels were similar between mutant and control animals by 7 and 14 days following doxycycline withdrawal. The restoration of normal intestinal morphology by 7 days after doxycycline removal correlated with a recovery in body weight (Tet-ODN89b-catenin-rtTA 26.4±0.4 versus control 27.0±0.5 g, P ¼ 0.67, Mann --Whitney, n ¼ 8) (Supplementary Figure 7) . Doxycycline-dependent activation of Wnt signaling in intestinal organoids To develop a system that allowed a kinetic analysis of early changes during oncogenic reversal, the tetracycline-inducible New 7 The potential toxicity of doxycycline was first analyzed using Axin2-LacZ organoids in the presence of R-spondin. At 2 mg/ml, doxycycline did not affect normal organoid growth or expression of Axin2-LacZ in the crypt compartment (Supplementary Figure 8) .
As previously described, the growth of the crypt culture organoids was dependent on the presence of the Wnt signaling regulator R-spondin (Figure 6a) . 7 Intestinal organoids cultured in the absence of R-spondin failed to develop crypt domains and instead formed spherical structures at 3 days that subsequently degenerated with high levels of cell death from 4 --5 days (Figure 6a ). However, in the absence of R-spondin, treatment with doxycycline (2 mg/ml) rescued the organoids from cell death (Figure 6a ). In this context, doxycycline induced expression of high levels of DN89b-catenin mRNA (29 000-fold; P ¼ 0.003, t-test, n ¼ 3) and activated Wnt target gene expression (Figures 6b and c) . Interestingly, the doxycycline/DN89b-catenin-rescued organoids formed abnormal crypts that lacked the characteristic tear-shaped structures observed in normal tissues and control organoids. These doxycycline-rescued structures contained goblet cells, in contrast with Cre þ APC fl/fl organoids (Supplementary Figure 9) . In addition, the doxycycline-stimulated structures showed low but uniform levels of Axin-2-lacZ expression as compared with the localized expression of Axin2-lacZ in the lower crypt region of uninduced structures treated with R-spondin (Figure 6a) .
To recapitulate the in vivo effect of doxycycline removal, doxycycline-containing culture medium was removed from the matrigel-embedded structures for 24 h after an initial 48 h of doxycycline treatment. Under these conditions DN89b-catenin mRNA levels were significantly reduced (P ¼ 0.02, t-test, n ¼ 3) leading to a strong reduction in Wnt target gene expression (Figures 6b and c) .
Tet-ODN89b-catenin-rtTA organoids, a useful in vitro system to screen for Wnt inhibitors CCT036477 is a recently identified small-molecule inhibitor of Wnt signaling that induced head and tail patterning defects in zebrafish embryos and inhibited the growth of colon cancer cell lines. 16 Tet-ODN89b-catenin-rtTA organoids were treated with 2 mg/ml doxycycline for 72 h, in the presence of 20uM CCT036477 for 4, 8, 12 and 24 h. No effect of CCT036477 was noted on the levels of three control RNAs (Supplementary Figure 10) . The strongest inhibitory response was observed after 4 h of CCT036477 exposure. The majority of the Wnt target genes (Ascl2, New approaches for anti-Wnt drug discovery T Jardé et al Ephb2, Lgr5 and Tiam1) were downregulated by 60 --90% ( Figure 7 ). Ascl2, Ephb2 and Lgr5 levels after 4 h of compound treatment were similar to that following 24 h of doxycycline removal suggesting that CCT036477 treatment was as effective as lowering b-catenin levels by 75% ( Figure 7 ). However, CCT036477 did not strongly affect Axin2 or C-myc expression. The reason that all Wnt targets were not similarly affected is unclear but may be related to the presence of multiple cell types that have different thresholds for Wnt responsiveness. After 8 and 12 h of CCT036477 exposure, inhibitory effects decreased and were weak by 24 h of exposure ( Figure 7 ). The reason for this loss of response is unclear but may be related to the stability of the compound in culture or to a time-dependent oscillation of transcript levels as a similar time dependence was observed in vivo following doxycycline removal (Figure 5c ). A similar type of response was observed in culture with another molecule that has more stable properties. Interestingly, this small molecule Wnt inhibitor recapitulated the in vitro responses in the in vivo system (unpublished data).
DISCUSSION
The majority of human colorectal cancers are initiated by inappropriate activation of the Wnt pathway. 8 Mechanisms that alter Wnt signaling involve the inactivation of the APC tumor suppressor or the stabilization of b-catenin by mutation of residues within its N-terminus. 17, 18 Several genetically encoded mouse models of Wnt pathway deregulation in the intestine have been established. 11, 19, 20 Both forced expression of DN89b-catenin or conditional APC deletion result in enlarged crypt compartments and increased levels of cell proliferation and apoptosis. 11, 19, 20 In the present study, doxycycline-dependent expression of DN89b-catenin was associated with comparable alterations suggesting that the doxycycline-inducible model system recapitulated early abnormalities that lead to colorectal cancer. The expression of DN89b-catenin did not change villus morphology or proliferation, suggesting that differentiated villus cells are unable to re-enter the cell cycle or to dedifferentiate. Similar observations were made following DN89b-catenin expression in villus cells directed by the Fabp1 promoter. 11 The aim of the in vivo study was to analyze the consequences of Wnt pathway inhibition in the mouse intestine as the removal of doxycycline should behave as an 'ideal' therapeutic modulator and should reverse oncogenic signaling, but not interfere with the restoration of normal crypt function. A combination of histological and molecular markers showed that ongoing DN89b-catenin expression in mice was necessary for the maintenance of the hyperplastic crypt phenotype and that loss of expression initiated a rapid cascade of responses that restored normal crypt morphology within 7 days (Figure 4) . Of particular note, Wnt target gene expression rapidly dropped to a level 3 --8 times lower than the control epithelium within 24 h. A feature of Wnt signaling is the role of multiple Wnt transcriptional targets (e.g., Dkk1, Axin2, b-TrCP, Nkd and T-cell factor-1) in negative feedback inhibition of signaling through mechanisms including the blocking of Wnt receptor function and the stabilization of the destruction complex. 21, 22 Here, we speculate that feedback Wnt inhibitor proteins accumulate following DN89b-catenin expression and act to repress basal levels of Wnt signaling below levels in normal tissues after doxycycline removal. Interestingly, the pattern of Wnt target gene expression observed in Figure 5b shows characteristics of a time-dependent dampened wave that might result a feedback inhibition mechanism that showed a degree of overcompensation.
An important question concerns the mechanism(s) involved in the rapid loss of crypt cells after Wnt pathway inhibition. In our study, about 70% of excess crypt cells were lost within 24 h of doxycycline withdrawal, suggesting that even earlier experimental time points might be useful to understand the earliest processes. We noted raised levels of apoptosis in the intestine 1 and 2 days after doxycycline removal. Raised levels of apoptosis were recently observed following treatment of acute myeloid leukemia cells with small molecule inhibitors of Wnt signaling and were associated with decreased expression of Wnt target proteins, such as C-myc. 23 Similarly, treatment of numerous cancer cell lines, including the breast, lung, mesothelioma and sarcoma, with a monoclonal anti-Wnt-1 antibody induced apoptosis and downregulation of Wnt pathway targets. 24 These results suggest that the downregulation of Wnt signaling enhances intestinal apoptosis during the reversal of the hyperplastic intestinal phenotype. However, it is important to note that the relationship between Wnt pathway activity and apoptosis is not always clear as Kuhnert et al. 6 observed that Dickkopf-1 adenoviral expression in mice repressed intestinal epithelial proliferation and Wnt target gene expression, but did not modify apoptotic levels.
Cell proliferation in the intestine was rapidly suppressed following doxycycline withdrawal in Tet-ODN89b-catenin-rtTA mice. However, although the hyperplastic phenotype was rapidly reversible, it is unknown whether polyp development or colorectal cancers generated by multiple cooperating mutations would be similarly dependent on continued Wnt signaling. Recently, using colorectal cancer cells containing a doxycycline-inducible b-catenin shRNAs system, Scholer-Dahirel et al. 25 demonstrated that sustained Wnt pathway activation was required for the maintenance of APC-mutated colorectal tumors in immunocompromised mice. Similarly, Gunther et al. 26 used a doxycyclineinducible approach to conditionally express the Wnt1 oncogene in the mammary gland. They noted that Wnt1-initiated mammary tumors completely regressed following doxycycline withdrawal. Coste et al. 27 demonstrated that an oncogenic b-catenin allele that was expressed sporadically in vivo did not result in intestinal tumorigenesis and speculated that b-catenin's oncogenic effect may require the presence of a field of mutant cells termed 'field cancerization'. Studies of mutant b-catenin in melanoma by contrast suggest that a 'just right' level of b-catenin expression (neither too high or low) may be necessary for tumorigenesis. 28 Future studies will be needed to determine whether intestinal tumors derived in the Tet-ODN89b-catenin-rtTA background will be similarly dependent on the maintenance of mutant b-catenin expression.
The aim of the in vitro study was to develop a crypt culture system that allowed a kinetic analysis of early changes during oncogenic reversal. Tetracycline-driven DN89b-catenin expression replaced the requirement for the Wnt pathway activator R-spondin in the growth of intestinal organoids, presumably by inducing expression of Wnt target genes required for cell survival. However, DN89b-catenin overexpression did not fully recapitulate the normal crypt morphology induced by R-spondin. Several explanations may account for the different phenotypes. Firstly, doxycycline-induced DN89b-catenin expression was probably expressed throughout the cultured crypts whereas R-spondin has been shown to enhance endogenous Wnt signals that may be localized to paneth cells at the base of the crypt. 29, 30 This contention is supported by the observation that Axin-2-lacZ was localized in R-spondin-treated structures but was broadly expressed when replaced by doxycycline-induced b-catenin expression. Secondly, DN89b-catenin overexpression may insufficient to a high enough level of Wnt target gene expression to drive a normal development program. The developmental and oncogenic outcomes of deregulated Wnt signaling vary from tissue to tissue and can be highly dependent on the absolute level of T-cell factor-dependent transcriptional activity. 31 Lastly, expression of DN89b-catenin may be unable to rescue branches of noncanonical Wnt signaling that are responsible for morphological aspects of crypt development. 32, 33 Using the in vitro system a small molecule Wnt pathway inhibitor was shown to downregulate DN89b-catenin-driven Wnt target gene expression. The early time point of maximal Wnttarget transcriptional response (4 h) emphasizes the importance of early analysis of drug action as the later responses may be masked by compound clearance/degradation. The early timescale of responses in vitro corresponded well with the rapid responses observed in vivo where maximal responses were observed within 24 h of doxycycline removal. Importantly, at later times in vivo, responses to compound may be obscured by a rebound in target transcripts levels that accompanies the restoration of normal levels of signaling.
In conclusion, we have shown that Wnt pathway upregulation induced a proliferative response in the intestine, and that the reversal of Wnt signaling rapidly restored the initial structure of the intestine. These observations provide evidence that downregulation of the Wnt pathway has potent anti-hyperplastic activities in vivo. Targeting oncogenic mutations involving the Wnt pathway, using a specific therapy, may therefore reverse an abnormal phenotype in vivo. As observed in this Tet-O mouse model, the effect of a 'gold standard' treatment targeting the Wnt pathway should induce an almost immediate response, with the first effects on target gene expression being observed within 24 h. Similarly, the in vitro system demonstrates that transcriptional response associated with the inhibition of Wnt signaling should be studied at early time points. These combinations of the in vitro and in vivo models provide a complementary pair of approaches for the discovery of inhibitors of Wnt signaling and intestinal tumorigenesis. For the first time these constitute a reversible system that can be used to characterize the early-stage compound efficacy before time-consuming medicinal chemistry is deployed to optimize hit compound pharmacodynamics.
MATERIALS AND METHODS

Generation of tet-O-b-catenin mutant mice
The pBS31 flp-in vector was engineered to contain the following four cassettes. The pgk promoter followed by an ATG and an FRT site. A splice acceptor double polyA cassette derived from the ROSA26 target vector. The CMV minimal promoter containing tetracycline response operator sequences from pTETOP and an SV40 polyA signal. 13, 34, 35 This aid rapid cloning of longer cDNAs, pBS31pgkATGFRTTet-O was converted into a gateway destination vector at the EcoR1 site. Human N-terminal myc-tagged DN89b-catenin cDNA was introduced into the vector by gateway cloning. Constructs were introduced into KH2 embryonic stem cells containing M2-rtTA under control of the endogenous ROSA26 promoter as described previously. 13 Mice were generated by diploid blastocyst injection into 3.5dpc blastocysts from C57/Bl6-J females. Approximately 30 injected blastocysts were transferred into pseudopregnant CD1 recipient females (Transgenic Facility, Wales Gene Park, Cardiff, UK). Chimeras were crossed with C57/BL6-J mice. The full method is described in Supplementary Method 1.
Crypt isolation and culture
Organoid culture was conducted as previously described. 7, 36 Crypts were released from small intestine tissue fragments by incubation for 30 min at 4 1C in 2mM EDTA-phosphate-buffered solution. Isolated crypts were mixed with 50 ml of Matrigel (BD Biosciences, Oxford, UK), seeded in 24-well plates and 500 ml of crypt culture medium (Dulbecco's modified Eagle medium/F12 containing 50 ng/ml epidermal growth factor (Sigma-Aldrich, Dorset, UK), 100 ng/ml Noggin (Peprotech, London, UK) and 600 ng/ml Rspondin 1 (R&D, Abingdon, Oxon, UK)) was added. Organoids were maintained in a 37 1C humidified atmosphere under 5% CO 2 .
Doxycycline induction and small molecule inhibitor treatment
Induction of DN89b-catenin expression in embryonic stem cells was achieved by culturing cells with 2 mg/ml doxycycline (Sigma) for 2 days. For in vivo induction, 8-week-old mice were fed 2 mg/ml doxycycline and 10 mg/ml sucrose in their drinking water for 10 days. Doxycycline was then withdrawn for periods up to 14 days (n ¼ 4 --6 for each group). Mice negative for Tet-ODN89 b-catenin and/or rtTA were used as controls.
For in vitro experiments, organoids were seeded in 24-well plates and 500 ml of R-spondin 1-free crypt culture medium containing 2 mg/ml doxycycline was added. After 2 days, culture medium was replaced by fresh medium containing 2 mg/ml doxycycline (for 24 h), both 2 mg/ml doxycycline (for 24 h) and 20 mM CCT036477 (for 4, 8, 12 and 24 h) or no doxycycline (for 24 h; n ¼ 3).
b-Galactosidase staining
Tet-ODN89b-catenin-rtTA mice were crossed with Axin2-LacZ mice, a direct reporter of canonical Wnt pathway activity. 37 b-Galactosidase staining was conducted as previously described. 20 
Immunoblot analysis
Proteins were extracted by scraping lysed embryonic stem cells from a confluent 10-cm 2 plate or by crushing liquid nitrogen-frozen intestinal tissues using a mortar and pestle. Equal amounts of cellular protein (80 mg) were separated on a 4 --12% Bis Tris Gel (Invitrogen, Paisley, UK) and transferred onto nitrocellulose membranes. Immunoblotting utilized antibodies against the myc epitope tag (1:1000, Sigma) and GAPDH as a protein loading control (1:5000, Chemicon/Millipore, Billerica, MA, USA).
Immunohistochemistry and immunofluorescence
Tissues were fixed in 10% formalin, paraffin embedded and cut into 5 mm sections for immunostaining. Briefly, slides were boiled for 20 min in antigen retrieval solution (Dako, Cambridgeshire, UK) followed by blocking in 0.3% hydrogen peroxide for 5 min, avidin/biotin solutions for 30 min (Vector, Peterborough, UK) and goat serum for 45 min (Vector). Slides where then incubated overnight with rabbit primary antibodies directed against Ki67 (1/500, Millipore, Billerica, MA, USA), lysozyme (1/400, Dako), mucin2 (1/500, Santa Cruz, Heidelberg, Germany), myc epitope tag (1/1500, Sigma), b-catenin (1/100, Cell Signaling, Danvers, MA, USA) or active caspase 3 (1/750, R&D Systems, Oxon, UK). After 1-h incubation with rabbit biotinylated secondary antibody, detection was carried out using a Vectastain ABC kit (Vector) for 30 min and visualized with DAB substrate chromogen for 10 min (Sigma).
For immunofluorescence, slides were treated as described above and were incubated overnight with anti-b-catenin antibody (1/1000, BD Transduction Laboratories, Oxford, UK). Slides were then exposed to Alexa Fluor 488 goat anti-mouse IgG (1/1000, Invitrogen) for 20 min and DAPI stained (1/5000). Fluorescent images were taken on an IX-71 inverted microscope (Olympus, Essex, UK) via an ORCA-ER camera utilising SimplePCI software (Hamamatsu Corporation, Hertfordshire, UK). Illumination intensity, exposure, offset and gain settings were maintained between samples.
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Scoring apoptosis and mitosis
Mitotic cells on Hematoxylin and eosin-stained sections were scored as previously described. 38 Fifty half crypts were counted for each mouse (n ¼ 4 --5 per group). In addition, the number of cells per villus was counted (50 half villus, n ¼ 4 --5 per group). Alkaline phosphatase staining was performed as described by the manufacturer (Fast Red Substrate System, Dako).
qRT --PCR
In all, 3 --5 mice of each genotype were harvested after 10-day doxycycline exposure and at 1, 2, 7, and 14 days following doxycycline removal. RNA was extracted from a 1-cm portion of small intestine taken B7 cm from the stomach and frozen in liquid N 2 . It is worth noting that intestinal RNA contains both crypt, villus and stromal/muscle tissues that dilute stem cell markers such as Lgr-5. The tissue was homogenized and RNA extracted using the RNeasy mini kit (Qiagen, Crawley, UK). DNA contamination was removed using the TurboDnase kit (Ambion, Huntingdon, UK). For in vitro experiments, matrigel was mechanically dissociated and organoids were pelleted by centrifugation at 1000 r.p.m. for 3 min. RNA was extracted using the RNeasy micro kit (Qiagen).
For both in vivo and in vitro experiments, 1 mg of total RNA was reverse transcribed using random hexamers (Promega, Southampton, UK) and Superscript III reverse transcriptase (Invitrogen). The qRT --PCR was performed using FastSybr Green Master Mix kit (Applied Biosystems, Life Technologies, Paisley, UK). Duplicate samples were analyzed on a StepOnePlus (Applied Biosystems) qRT --PCR machine using the fast protocol. b-Actin, b-2 microglobulin and keratin 20 primers were used to equalize the data. Threshold cycle values and the 2-DDCT method were used to calculate expression changes. The Supplementary Table 1 contains the list of primers used in this study.
